AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2016
Nov 2, 2016
284_dirs_2016-11-02_4cd9b8f5-cf45-4c57-a9e2-1997a5ffae60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2016-11-02
Reporting Person: WENDELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-02 | Common Stock | M | 5000.0000 | $51.8600 | Acquired | 6000.0000 | Direct |
| 2016-11-02 | Common Stock | S | 5000.0000 | $59.5000 | Disposed | 1000.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-02 | Stock Option (right to buy) | $51.8600 | M | 5000.0000 | Disposed | 2017-04-26 | Common Stock (5000.0000) | Direct |
Footnotes
F1: The option became exercisable in equal installments on 4/27/2008, 4/27/2009 and 4/27/2010.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30